Jpmorgan Chase & CO Zimmer Biomet Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,081,381 shares of ZBH stock, worth $195 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,081,381
Previous 556,663
273.9%
Holding current value
$195 Million
Previous $58.8 Million
300.63%
% of portfolio
0.02%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ZBH
# of Institutions
1,114Shares Held
185MCall Options Held
577KPut Options Held
314K-
Vanguard Group Inc Valley Forge, PA23.1MShares$2.16 Billion0.05% of portfolio
-
Dodge & Cox San Francisco, CA19.6MShares$1.84 Billion1.35% of portfolio
-
Black Rock Inc. New York, NY16.8MShares$1.58 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD14.5MShares$1.36 Billion0.2% of portfolio
-
State Street Corp Boston, MA8.75MShares$822 Million0.04% of portfolio
About ZIMMER BIOMET HOLDINGS, INC.
- Ticker ZBH
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 209,820,000
- Market Cap $19.7B
- Description
- Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...